Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Renub Research | PRODUCT CODE: 1759823

Cover Image

PUBLISHER: Renub Research | PRODUCT CODE: 1759823

Japan Cataract Surgery Devices Market Trends 2025-2033

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2990
PDF (5 User License + Excel)
USD 3490
PDF (Corporate License)
USD 3990

Add to Cart

Japan Cataract Surgery Devices Market Size

Japan Cataract Surgery Devices Market is expected to reach US$ 540.64 million by 2033 from US$ 410.75 million in 2024, with a CAGR of 3.10% from 2025 to 2033. An aging population, an increase in the prevalence of cataracts, technological developments in surgical equipment, rising healthcare costs, government assistance for senior care, better surgical results, and a growing desire for minimally invasive procedures are the main factors propelling the Japanese market for cataract surgery devices.

Japan Cataract Surgery Devices Market Report by Product Type (Intraocular Lens, Phacoemulsification Systems, Femtosecond Laser, Ophthalmic Viscoelastic Devices and Other Consumables), End Use (Hospitals, Ophthalmic Clinics, Research Institutes), Region and Company Analysis 2025-2033.

Japan Cataract Surgery Devices Industry Overview

A clouded natural lens is removed and replaced with an artificial intraocular lens (IOL) during cataract surgery procedures, which are performed using specialized medical tools and equipment known as cataract surgery devices. Phacoemulsification machines, which break up cataracts using ultrasonic energy; femtosecond lasers, which make precise incisions; ophthalmic viscoelastic devices (OVDs), which preserve the structure of the eye during surgery; and other surgical tools and IOLs are important technologies. These tools improve visual results, shorten recuperation times, and increase surgical accuracy. Cataract surgery is becoming safer, quicker, and more effective because to technological developments, which also greatly improve patients' quality of life everywhere.

The market for cataract surgical devices in Japan is expanding steadily, mostly due to the nation's increasingly aging population, which raises the prevalence of cataracts considerably. The demand for contemporary technologies has been fueled by technological breakthroughs that have increased surgical precision and patient outcomes, such as femtosecond laser-assisted cataract surgery (FLACS), high-end intraocular lenses (IOLs), and upgraded imaging systems. Advanced surgical equipment is used in Japan because of its well-established healthcare system, strong emphasis on innovation, and highly qualified workforce. The industry is also expanding as a result of government programs supporting cutting-edge medical technology and rising public knowledge of eye health and available treatments.

Growth Drivers for the Japan Cataract Surgery Devices Market

Aging Population

One of the main factors propelling Japan's market for cataract surgery equipment is the country's aging population. In 2023, more than 10% of Japan's population was 80 years of age or older, making it one of the oldest countries in the world, according to the World Economic Forum's September 2023 report. In addition, 36.23 million Japanese citizens, or roughly one in three, were over 65 in that year. The need for cataract procedures has increased dramatically as a result of this demographic transition, as cataracts primarily afflict older persons. The growing elderly population requires advanced surgical devices such as femtosecond lasers, phacoemulsification machines, and premium intraocular lenses (IOLs) to improve vision and quality of life. The aging population's constant need is fueling innovation and growth in Japan's market for cataract surgery equipment.

Technological Advancements

The market for cataract surgery devices in Japan is expanding due in large part to technological improvements. By providing precise, bladeless incisions, improving surgical precision, and shortening recuperation times, innovations such as femtosecond laser-assisted cataract surgery (FLACS) have completely changed processes. Furthermore, the creation of high-end intraocular lenses (IOLs), like multifocal and extended depth of focus lenses, has enhanced visual results and met the various refractive needs of patients. The precision and customization of treatment plans are further enhanced by the use of artificial intelligence (AI) and machine learning into surgical and diagnostic instruments. The market is expanding as a result of these technological advancements and Japan's strong healthcare system, which help to address the country's growing demand for cataract procedures.

Healthcare Infrastructure

The market for cataract surgical instruments in Japan is expanding at a substantial rate owing to its sophisticated healthcare system. Modern surgical technologies like femtosecond lasers, phacoemulsification systems, and high-end intraocular lenses (IOLs) are available at the country's reputable medical institutions, which include hospitals and specialty ophthalmology clinics. These facilities employ highly qualified ophthalmic surgeons who are knowledgeable about the most recent surgical methods, guaranteeing top-notch treatment and the best possible results for patients. Furthermore, the Pharmaceuticals and Medical Devices Agency (PMDA) oversees Japan's strong regulatory environment, which guarantees the effectiveness and safety of medical devices, building confidence and promoting the use of cutting-edge cataract surgery technology. Japan is positioned as a leader in cataract surgery, satisfying the growing demand brought on by its aging population because to the combination of technological innovation and a robust healthcare system.

Challenges in the Japan Cataract Surgery Devices Market

High Cost of Advanced Devices

One major obstacle facing the Japanese market is the high cost of sophisticated cataract surgery equipment. Due to their high cost, technologies like femtosecond lasers, high-end intraocular lenses (IOLs), and sophisticated phacoemulsification equipment are less affordable for smaller clinics and hospitals. Furthermore, patients are financially burdened because these expenses are frequently not entirely covered by Japan's national health insurance, particularly for premium IOLs. This hinders the broad adoption of state-of-the-art technologies, resulting in inequalities in the quality of care and limiting the market's overall growth for cataract surgical devices, especially outside of major cities.

Regulatory Hurdles

The market for cataract surgery devices in Japan is severely hampered by regulatory barriers. To guarantee the security and effectiveness of medical equipment, the Pharmaceuticals and Medical equipment Agency (PMDA) implements stringent and intricate approval procedures. Although necessary for patient safety, these rules may impede market agility and competition by delaying the adoption of cutting-edge technologies. Manufacturers must spend more time and money bringing innovative technologies to market due to lengthy clinical trials, copious documentation, and regulatory requirements. Navigating Japan's distinct regulatory environment presents extra challenges for foreign businesses, which could impede the nation's uptake of cutting-edge cataract surgery techniques.

Japan Cataract Surgery Devices Market Segmentation:

Product Type

  • Intraocular Lens
  • Phacoemulsification Systems
  • Femtosecond Laser
  • Ophthalmic Viscoelastic Devices and Other Consumables

End Use

  • Hospitals
  • Ophthalmic Clinics
  • Research Institutes

Region

  • East
  • South
  • North
  • West

All companies have been covered from 4 viewpoints:

  • Company Overview
  • Key Persons
  • Recent Development & Strategies
  • Sales Analysis

Key Players Analysis

  • Alcon, Inc.
  • Johnson & Johnson
  • Carl Zeiss Meditec AG
  • Bausch & Lomb, Inc.
  • Topcon Corp
  • STAAR Surgical Co
  • Glaukos Corp
  • Abbott Laboratories

Table of Contents

1. Introduction

2. Research & Methodology

  • 2.1 Data Source
    • 2.1.1 Primary Sources
    • 2.1.2 Secondary Sources
  • 2.2 Research Approach
    • 2.2.1 Top-Down Approach
    • 2.2.2 Bottom-Up Approach
  • 2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Japan Cataract Surgery Devices Market

  • 5.1 Historical Market Trends
  • 5.2 Market Forecast

6. Market Share Analysis

  • 6.1 By Product Type
  • 6.2 By End Use
  • 6.3 By Region

7. Product Type

  • 7.1 Intraocular Lens
  • 7.2 Phacoemulsification Systems
  • 7.3 Femtosecond Laser
  • 7.4 Ophthalmic Viscoelastic Devices and Other Consumables

8. End Use

  • 8.1 Hospitals
  • 8.2 Ophthalmic Clinics
  • 8.3 Research Institutes

9. Region

  • 9.1 East
  • 9.2 South
  • 9.3 North
  • 9.4 West

10. Porter's Five Forces Analysis

  • 10.1 Bargaining Power of Buyers
  • 10.2 Bargaining Power of Suppliers
  • 10.3 Degree of Rivalry
  • 10.4 Threat of New Entrants
  • 10.5 Threat of Substitutes

11. SWOT Analysis

  • 11.1 Strength
  • 11.2 Weakness
  • 11.3 Opportunity
  • 11.4 Threat

12. Key Players Analysis

  • 12.1 Alcon, Inc.
    • 12.1.1 Overview
    • 12.1.2 Key Persons
    • 12.1.3 Recent Development & Strategies
    • 12.1.4 Revenue Analysis
  • 12.2 Johnson & Johnson
    • 12.2.1 Overview
    • 12.2.2 Key Persons
    • 12.2.3 Recent Development & Strategies
    • 12.2.4 Revenue Analysis
  • 12.3 Carl Zeiss Meditec AG
    • 12.3.1 Overview
    • 12.3.2 Key Persons
    • 12.3.3 Recent Development & Strategies
    • 12.3.4 Revenue Analysis
  • 12.4 Bausch & Lomb, Inc.
    • 12.4.1 Overview
    • 12.4.2 Key Persons
    • 12.4.3 Recent Development & Strategies
    • 12.4.4 Revenue Analysis
  • 12.5 Topcon Corp
    • 12.5.1 Overview
    • 12.5.2 Key Persons
    • 12.5.3 Recent Development & Strategies
    • 12.5.4 Revenue Analysis
  • 12.6 STAAR Surgical Co
    • 12.6.1 Overview
    • 12.6.2 Key Persons
    • 12.6.3 Recent Development & Strategies
    • 12.6.4 Revenue Analysis
  • 12.7 Glaukos Corp
    • 12.7.1 Overview
    • 12.7.2 Key Persons
    • 12.7.3 Recent Development & Strategies
    • 12.7.4 Revenue Analysis
  • 12.8 Abbott Laboratories
    • 12.8.1 Overview
    • 12.8.2 Key Persons
    • 12.8.3 Recent Development & Strategies
    • 12.8.4 Revenue Analysis
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!